Endo International plc (NASDAQ: ENDP) today announced that its Par Sterile Products business will supply VASOSTRICT®, vasopressin injection, USP, vial presentations to healthcare providers through Premier's Premier ProRx® program, helping to maintain supply continuity for a medication needed in critical care, including some of the most acute cases of COVID-19.
https://finance.yahoo.com/news/endo-announces-agreement-premier-supply-123000575.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.